BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists

Rheumatology (Oxford). 2008 Jun;47(6):924-5. doi: 10.1093/rheumatology/kel216a. Epub 2006 Aug 28.
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • Antirheumatic Agents / adverse effects
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / drug therapy*
  • Drug Monitoring / methods
  • Evidence-Based Medicine
  • Humans
  • Interprofessional Relations
  • Medical Audit

Substances

  • Antirheumatic Agents